1. Home
  2. STT vs BDX Comparison

STT vs BDX Comparison

Compare STT & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo State Street Corporation

STT

State Street Corporation

HOLD

Current Price

$155.22

Market Cap

43.1B

Sector

Finance

ML Signal

HOLD

Logo Becton Dickinson and Company

BDX

Becton Dickinson and Company

HOLD

Current Price

$147.23

Market Cap

51.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STT
BDX
Founded
1792
1897
Country
United States
United States
Employees
51425
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.1B
51.5B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
STT
BDX
Price
$155.22
$147.23
Analyst Decision
Buy
Buy
Analyst Count
14
13
Target Price
$148.86
$186.00
AVG Volume (30 Days)
1.5M
2.9M
Earning Date
04-17-2026
05-07-2026
Dividend Yield
2.23%
2.89%
EPS Growth
N/A
N/A
EPS
N/A
0.25
Revenue
N/A
$21,840,000,000.00
Revenue This Year
$7.66
N/A
Revenue Next Year
$3.87
$3.02
P/E Ratio
$13.80
$590.36
Revenue Growth
N/A
8.24
52 Week Low
$94.72
$141.82
52 Week High
$159.31
$213.08

Technical Indicators

Market Signals
Indicator
STT
BDX
Relative Strength Index (RSI) 60.18 46.38
Support Level $147.61 $141.82
Resistance Level $156.18 $158.66
Average True Range (ATR) 2.92 4.07
MACD -0.14 0.73
Stochastic Oscillator 66.22 56.95

Price Performance

Historical Comparison
STT
BDX

About STT State Street Corporation

State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $54 trillion in assets under custody and administration, and $5.7 trillion in assets under management, as of Dec. 31, 2025, State Street operates globally in more than 100 geographic markets and employs about 51,500 worldwide.

About BDX Becton Dickinson and Company

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.

Share on Social Networks: